Gufic Biosciences Announces Special Window for Share Transfer & Dematerialization
Gufic Biosciences opens a special window for physical share transfer and dematerialization from February 5, 2026, to February 4, 2027. This allows shareholders who sold securities before April 1, 2019, to lodge transfer deeds. Transferred securities will be locked in for one year.
This is a procedural announcement related to share transfers and dematerialization, not directly impacting the company's core business operations or financial performance.
The announcement is a routine regulatory filing providing information about a special window for share transfers and dematerialization, with no immediate financial or operational impact.
Gufic Biosciences Limited has announced a special window for the re-lodgement of transfer deeds related to physical securities and for dematerialization. This initiative, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, commenced on February 05, 2026, and will remain open until February 04, 2027.
The special window is available for shareholders who sold or purchased physical securities before April 01, 2019, and for cases where transfer requests were previously rejected or returned due to deficiencies. To be eligible, requests must be accompanied by original certificates, transfer deeds, and all necessary supporting documents. Securities transferred under this window will be credited to the transferee in demat mode only and will be subject to a one-year lock-in period from the date of transfer registration, during which they cannot be transferred, lien-marked, or pledged.
Shareholders can contact the company's Registrar and Transfer Agent, MUFG Intime India Private Limited, or Gufic Biosciences Limited's corporate office for any queries or assistance within the specified period. The company urges eligible shareholders to utilize this opportunity.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.